Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)


Patients are in an ideal position to identify the impact of medicines they have taken, particularly on their quality of life. Systems for patients/consumer reporting are an important tool to facilitate and encourage ‘spontaneous reporting’, which in turn contributes to the overall knowledge of the safety of a medicine and the patient experience. The patients’ role in reporting adverse drug reactions is a key element in building an improved system of pharmacovigilance which monitors the benefit and risk profiles of our pharmaceutical products. Pharmacovigilance helps determine the best conditions of use for treatments, and provides physicians, healthcare professionals and patients with comprehensive, up-to-date safety information, including potential risks associated with a product.

 

You may report any drug-related problem concerning EIPICo's medicinal products through: 

  • Electronically please click the link below :
    Report......Your Report Counts, Click here.   
  • Email: Pharmacovigilance@eipico.net
  • Landline No.: (+2) 0224143660 - 0224143550 Ext: 505 - 509
  • Fax No.: (+2) 0224174528 – 0224143800
  • Mobile No.: (+2) 01005870200 / (+2) 01023222791

For reporting drug-related Problems in the Kingdom of Saudi Arabia through Egyptian International Pharmaceutical Industries Co. (EIPICO) Pharmacovigilance Department

Address: 3046 Al Imam Faisal Ibn Turki Ibn Abdullah Khaldia Towers, Al Futah District Building No. 4, Floor No. 22, Office No. 42201 Riyadh 12632 – 7742, Saudi Arabia 
Tel.: +966-11-4056428 # 121/115/116 
Fax: +966-11-4123969 
Email: icsrs.ksa@eipico.net 








Request Medical Resources

If you have a general question about EIPICO medicines

Click here






WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1345321